Douglas H. Thamm
Directeur Technique/Scientifique/R&D chez Csu Flint Animal Cancer Center
Profil
Douglas H.
Thamm is currently the Director of Clinical Research at CSU Flint Animal Cancer Center, Head of Clinical Development at VetDC, Inc., and a Member of the Cell & Molecular Biology Graduate Program at Colorado State University.
He received his undergraduate and doctorate degrees from the University of Pennsylvania.
Postes actifs de Douglas H. Thamm
| Sociétés | Poste | Début |
|---|---|---|
VetDC, Inc.
 VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Corporate Officer/Principal | - |
| Csu Flint Animal Cancer Center | Directeur Technique/Scientifique/R&D | - |
| Colorado State University | Corporate Officer/Principal | - |
Formation de Douglas H. Thamm
| University of Pennsylvania | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
VetDC, Inc.
VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Process Industries |
| Csu Flint Animal Cancer Center |
